Gyre Therapeutics Balance Sheet (2010-2026) | GYRE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	73.62M	64.53M	46.85M	34.82M	75.39M	23.10M	25.18M	8.10M	11.53M	2.23M	10.58M	8.68M	16.10M	15.87M	11.80M	15.00M	28.64M	27.22M	37.07M	37.50M
Short-term Investments (Quarter)	12.90M	5.37M	2.50M									7.60M	9.00M	9.23M	14.86M	14.80M	17.87M	19.60M	15.36M	12.31M
Cash & Current Investments (Quarter)	86.52M	69.90M	49.35M	34.82M	75.39M	23.10M	25.18M	8.10M	11.53M	2.23M	10.58M	16.28M	25.10M	25.09M	26.66M	29.80M	46.52M	46.82M	52.42M	49.81M
Receivables - Net (Quarter)	1.97M	1.11M	1.82M	0.56M	5.00M	5.00M	17.14M	5.00M			15.20M	15.21M	18.46M	19.49M	19.59M	22.29M	24.86M	26.57M	31.08M	26.58M
Receivables - Other (Quarter)									0.30M	1.20M	0.80M	0.80M	0.80M	1.30M	0.23M	0.20M	0.20M	0.20M	0.23M	0.20M
Receivables (Quarter)	1.97M	1.11M	1.82M	0.56M	5.00M	5.00M	17.14M	5.00M			16.00M	16.01M	19.26M	20.79M	19.82M	22.49M	25.06M	26.77M	31.31M	26.78M
Raw Materials (Quarter)							1.06M				0.92M	0.72M	1.17M	1.04M	0.79M	1.17M	1.21M	1.10M	0.97M	1.17M
Work In Process (Quarter)							3.67M				2.00M	2.53M	2.92M	3.54M	2.93M	3.43M	4.21M	4.43M	6.31M	5.99M
Finished Goods (Quarter)							1.40M				1.36M	1.68M	1.55M	1.80M	2.61M	3.28M	3.44M	3.32M	2.89M	4.18M
Inventory (Quarter)							6.12M				4.28M	4.94M	5.63M	6.38M	6.34M	7.88M	8.86M	8.85M	10.17M	11.35M
Prepaid Assets (Quarter)	8.33M	8.32M	2.81M	1.32M	0.91M	2.16M	0.84M	0.92M	0.70M	1.17M	1.55M	1.79M	1.72M	1.51M	1.19M	8.16M	2.70M	2.87M	1.34M	3.76M
Current Assets (Quarter)	96.83M	73.96M	51.48M	36.70M	81.31M	30.25M	49.65M	14.01M	7.62M	5.13M	57.22M	62.72M	53.52M	54.81M	64.79M	68.45M	91.28M	98.58M	102.37M	91.73M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.68M	1.09M	0.97M	0.86M	0.16M	0.12M	17.71M	0.00M			23.29M	23.56M	23.67M	24.44M	23.88M	23.52M	23.40M	23.61M	23.60M	23.57M
Long-Term Investments (Quarter)							40.63M				4.72M				64.31M				107.05M
Intangibles (Quarter)							0.30M				0.70M	0.60M	0.60M	0.18M	0.27M	5.08M	4.96M	4.85M	5.75M	5.84M
Goodwill & Intangibles (Quarter)							0.30M				0.70M	0.60M	0.60M	0.18M	0.27M	5.08M	4.96M	4.85M	5.75M	5.84M
Long-Term Deferred Tax (Quarter)							4.08M				4.70M	5.00M	5.08M	5.16M	5.62M	5.82M	6.13M	6.71M	6.87M	7.72M
Other Non-Current Assets (Quarter)	1.17M	0.87M	0.47M	0.47M	0.17M	0.17M	3.39M	0.17M	0.17M	0.17M	0.99M	0.80M	1.28M	2.77M	3.03M	5.56M	5.34M	5.32M	2.49M	4.94M
Non-Current Assets (Quarter)	4.96M	4.57M	4.19M	3.57M	2.06M	0.77M	35.10M	4.74M	4.77M	4.83M	59.32M	59.29M	67.41M	70.43M	60.62M	61.34M	61.36M	60.81M	63.76M	70.28M
Assets (Quarter)	101.79M	78.54M	55.66M	40.27M	83.37M	31.02M	84.75M	18.75M	12.39M	9.96M	116.54M	122.01M	120.93M	125.24M	125.41M	129.79M	152.65M	159.38M	166.13M	162.01M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	1.83M	3.86M	6.42M	4.71M	1.04M	0.04M	0.12M	0.02M	0.01M	0.16M	0.35M	0.33M	0.27M	0.30M	0.11M	0.12M	0.07M	0.56M	0.12M	0.27M
Notes Payables (Quarter)
Dividends payables (Quarter)							7.56M
Payables (Quarter)	1.83M	3.86M	6.42M	4.71M	1.04M	0.04M	7.68M	0.02M	0.01M	0.16M	0.35M	0.33M	0.27M	0.30M	0.11M	0.12M	0.07M	0.56M	0.12M	0.27M
Accumulated Expenses (Quarter)	2.52M	2.55M	0.18M	2.14M	0.91M	1.04M	9.26M	1.08M	0.27M	0.71M	11.94M	10.77M	10.51M	9.55M	10.62M	17.24M	14.92M	11.80M	14.35M	15.41M
Other Accumulated Expenses (Quarter)	7.37M	8.14M	4.07M	4.44M	0.95M	0.18M	0.12M	0.74M	2.07M	0.92M	1.37M	1.36M	1.48M	1.29M	0.23M	0.23M	0.22M	0.23M	0.23M	0.23M
Short term Debt (Quarter)
Current Leases (Quarter)	1.81M	1.84M	1.98M	1.91M	1.42M	0.38M	0.49M				0.21M	0.10M	0.66M	0.69M	0.71M	0.81M	0.62M	0.63M	0.64M	0.75M
Current Taxes (Quarter)							2.10M				5.05M	6.47M	2.26M	2.84M	2.83M	0.57M	1.08M	2.65M	2.94M	3.13M
Current Deferred Revenue (Quarter)	2.04M	0.85M	0.23M				0.14M				0.04M	0.04M	0.06M	0.04M	0.06M	0.03M		0.06M	0.01M
Total Current Liabilities (Quarter)	15.57M	17.25M	14.16M	13.19M	4.31M	1.64M	12.24M	6.84M	2.79M	1.78M	20.05M	19.49M	15.57M	14.72M	19.52M	18.99M	16.92M	15.91M	18.29M	19.79M
Non-Current Liabilities
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)							0.12M				0.21M	0.20M	0.19M	0.18M	0.93M	0.91M	0.88M	0.87M	0.85M	0.84M
Preferred Stock Liabilities (Quarter)							33.31M	33.31M	33.31M		64.53M
Minority Interest (Quarter)							29.70M				29.78M	32.13M	32.99M	35.30M	35.08M	36.18M	37.42M	35.49M	36.25M	35.68M
Non-Current Deferred Tax Liability (Quarter)											2.50M				8.30M				9.60M
Operating Leases (Quarter)	1.05M	0.55M	0.41M				0.12M				0.20M	0.17M	1.30M	1.10M	0.89M	0.78M	0.77M	0.54M	0.30M	0.07M
Other Non-Current Liabilities (Quarter)							0.06M	9.55M	4.61M	4.66M	4.72M	8.55M	10.47M	10.76M	10.63M	1.40M	3.20M	3.22M	1.45M	2.87M
Total Non-Current Liabilities (Quarter)							12.48M	1.84M	2.79M	1.78M	33.34M	24.69M	17.11M	16.00M	16.38M	24.09M	20.00M	18.75M	22.40M	22.16M
Total Liabilities (Quarter)	16.62M	17.80M	14.57M	13.19M	4.31M	1.64M	12.54M	11.39M	7.40M	6.45M	38.06M	33.24M	27.58M	26.77M	27.00M	25.49M	23.20M	21.97M	23.85M	25.03M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	85.16M	60.74M	59.47M	27.08M	79.06M	29.38M	72.22M	77.33M	77.47M	85.32M	13.95M	88.77M	93.35M	98.47M	98.40M	104.30M	129.44M	101.92M	106.03M	101.31M
Shareholder's Equity (Quarter)	85.16M	60.74M	59.47M	27.08M	79.06M	29.38M	72.22M	77.33M	77.47M	85.32M	13.95M	88.77M	93.35M	98.47M	63.32M	104.30M	129.44M	101.92M	142.28M	136.99M
Liabilities and Shareholders Equity (Quarter)	101.79M	78.54M	55.66M	40.27M	83.37M	31.02M	84.75M	18.75M	12.39M	9.96M	116.54M	122.01M	120.93M	125.24M	125.41M	129.79M	152.65M	159.38M	166.13M	162.01M
Retained Earnings (Quarter)	-357.10M	-382.40M	-402.69M	-417.20M	-365.60M	-370.48M	-0.39M	-410.70M	-413.10M	-414.70M	-1.64M	-78.00M	-74.48M	-73.40M	-2.60M	-70.75M	-70.30M	-1.70M	-68.40M	-77.67M
Preferred Shares (Quarter)										33.31M
Treasury Shares (Quarter)

Research Tools

Gyre Therapeutics Balance Sheet (2010-2026) | GYRE

Create an account

Sign In

Reset Password